Puretech Health Plc ADR (PRTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRTC | AZN | AMGN | GILD | BMY |
| Company | Puretech Health Plc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 17.43 | 180.58 | 345.87 | 130.57 | 55.75 |
| High | 17.84 | 183.37 | 349.18 | 131.04 | 56.78 |
| Low | 17.25 | 180.24 | 342.25 | 128.01 | 55.55 |
| Latest | 17.42 | 181.80 | 345.60 | 129.18 | 56.60 |
| Change | +0.34 | +5.52 | +7.38 | +0.19 | +1.88 |
| % Change | +1.99% | +3.13% | +2.18% | +0.15% | +3.44% |
| Volume | 7,100 | 2,030,300 | 2,907,000 | 13,729,200 | 12,659,100 |
| 20-Day Average Volume | 18,425 | 1,895,470 | 2,447,225 | 7,197,020 | 11,172,215 |
| Previous Close | 17.08 | 176.28 | 338.22 | 128.99 | 54.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.33 | 183.90 | 333.78 | 131.96 | 56.91 |
| 20-Day Raw Stochastic | 30.55% | 42.60% | 87.31% | 20.23% | 39.67% |
| 20-Day Relative Strength | 51.59 | 44.33 | 54.48 | 43.03 | 47.03 |
| Weighted Alpha | -2.98 | +18.77 | +17.51 | +11.17 | +17.00 |
| Today's Opinion | 24% Buy | 24% Sell | 16% Buy | 24% Sell | 8% Sell |
| Previous Opinion | 24% Sell | 40% Sell | 24% Sell | 24% Sell | 24% Sell |
| Last Month's Opinion | 8% Sell | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.51% since 05/13/26 | -1.90% since 05/28/26 | +2.71% since 05/28/26 | -5.17% since 05/28/26 | -0.54% since 05/28/26 |
| Low | 16.73 on 05/18/26 | 174.60 on 06/03/26 | 322.30 on 06/02/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 18.61 on 05/14/26 | 187.10 on 05/29/26 | 349.18 on 06/04/26 | 137.20 on 05/29/26 | 57.45 on 06/01/26 |
| 1-Month | |||||
| %Chg | -5.12% since 04/20/26 | -0.90% since 05/04/26 | +6.72% since 05/04/26 | -2.65% since 05/04/26 | -1.36% since 05/04/26 |
| Low | 16.58 on 05/05/26 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 19.33 on 05/01/26 | 191.50 on 05/21/26 | 349.18 on 06/04/26 | 137.50 on 05/12/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | -1.08% since 02/20/26 | -9.79% since 03/04/26 | -8.88% since 03/04/26 | -12.85% since 03/04/26 | -9.19% since 03/04/26 |
| Low | 14.50 on 03/30/26 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 19.33 on 05/01/26 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 6-Month | |||||
| %Chg | +8.37% since 11/20/25 | +0.97% since 12/04/25 | +1.60% since 12/04/25 | +5.35% since 12/04/25 | +8.95% since 12/04/25 |
| Low | 14.50 on 03/30/26 | 174.60 on 06/03/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 19.92 on 01/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 424,037 | 273,394,048 | 182,540,032 | 160,150,112 | 111,742,128 |
| Shares Outstanding, K | 24,342 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 4,660,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -109,740,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | N/A | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.15 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 07/29/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.16 | 14.85 | 15.24 | 9.18 |